Abstract:RNA polymerase III (Pol III) activity in cancer is linked to the production of small noncoding (nc)RNAs that are otherwise silent in most tissues. snaR-A (small NF90-associated RNA isoform A) - a hominid-specific ncRNA shown to enhance cell proliferation, migration, and invasion - is a cancer-emergent Pol III product that remains largely uncharacterized despite promoting growth phenotypes. Here, we applied a combination of genomic and biochemical approaches to study the biogenesis and subsequent protein interactions of snaR-A and to better understand its role as a putative driver of cancer progression. By profiling the chromatin landscapes across a multitude of primary tumor types, we show that predicted snaR-A upregulation is broadly linked with unfavorable outcomes among cancer patients. At the molecular level, we unexpectedly discover widespread interactions between snaR-A and mRNA splicing factors, including SF3B2 - a core component of the U2 small nuclear ribonucleoprotein (snRNP). We find that SF3B2 levels are sensitive to high snaR-A abundance and that depletion of snaR-A alone is sufficient to decrease intron retention levels across subpopulations of mRNA enriched for U2 snRNP occupancy. snaR-A sensitive genes are characterized by high GC content, close spatial proximity to nuclear bodies concentrated in pre-mRNA splicing factors, and functional enrichment for proteins involved in deacetylation and autophagy. We highlight examples of splicing misregulation and increased protein levels following snaR-A depletion for a wide-ranging set of factors, suggesting snaR-A-driven splicing defects may have far-reaching effects that re-shape the cellular proteome. These findings clarify the molecular activities and consequences of snaR-A in cancer, and altogether establish a novel mechanism through which Pol III overactivity may promote tumorigenesis.

What problem does this paper attempt to address?

The core problem that this paper attempts to solve is to explore the molecular mechanism of snaR - A (a small non - coding RNA related to cancer) in cancer and its impact on mRNA splicing. Specifically, the author hopes to reveal its role as a potential driver of cancer progression by studying the biogenesis of snaR - A, protein - protein interactions, and its interference in the splicing process of specific mRNA subpopulations. ### Main problems and research objectives of the paper 1. **The relationship between snaR - A expression and the prognosis of cancer patients**: - By analyzing the chromatin landscapes of multiple primary tumor types, researchers found that the predicted up - regulation of snaR - A is closely related to the poor prognosis of cancer patients. 2. **The interaction between snaR - A and splicing factors**: - At the molecular level, researchers unexpectedly found that snaR - A widely interacts with mRNA splicing factors, especially with SF3B2, a core component of U2 small nuclear ribonucleoprotein (snRNP). - Further research shows that the level of SF3B2 is sensitive to high - abundance snaR - A, and depleting snaR - A alone is sufficient to reduce the level of intron retention in the mRNA subpopulation enriched in U2 snRNP - occupied regions. 3. **Characteristics of snaR - A - sensitive genes**: - snaR - A - sensitive genes have a high GC content, are close to nuclear bodies rich in pre - mRNA splicing factors, and are functionally enriched in proteins involved in deacetylation and autophagy. 4. **The impact of snaR - A depletion on splicing and protein levels**: - Researchers provided multiple examples showing that after snaR - A depletion, widespread splicing dysregulation and increased protein levels occur, indicating that snaR - A - driven splicing defects may have a profound impact on the cellular proteome. 5. **The association between snaR - A and nuclear speckles**: - Through fluorescence in situ hybridization experiments, researchers found that snaR - A is mainly located in the nuclear speckle area adjacent to SON - marked regions, suggesting that snaR - A may interfere with the splicing process near or within nuclear speckles. ### Summary This study, through the integration of genomics and biochemical methods, deeply explored the mechanism of action of snaR - A in cancer, especially how it promotes cancer development by interfering with mRNA splicing. These findings not only clarify the molecular activities of snaR - A and their consequences but also reveal new insights into the possible new mechanisms by which Pol III over - activity may promote tumorigenesis. ### Formula display There are few formulas involved in the paper, but to ensure the correct format, here is an example formula in Markdown format: ```markdown $$ HR=\frac{\text{Risk Ratio}}{\text{Confidence Interval}} $$ ``` Here, HR represents the Hazard Ratio, which is used to assess the impact of snaR - A expression status on patient survival rates.

Cancer-associated snaR-A noncoding RNA interacts with core splicing machinery and disrupts processing of mRNA subpopulations

A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS

Biological function of long noncoding RNA snaR in HER2-positive breast cancer cells

SRSF6-regulated Alternative Splicing That Promotes Tumour Progression Offers a Therapy Target for Colorectal Cancer

High-grade ovarian cancer associated H/ACA snoRNAs promote cancer cell proliferation and survival

RNA splicing dysregulation and the hallmarks of cancer

Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes

Small non-coding RNAs in human cancer: function, clinical utility, and characterization

Signaling Pathways Driving Aberrant Splicing in Cancer Cells

Novel Cancer-Promoting Functions and Mechanisms for snoRNAs

Analysis of the Effect of SNAI Family in Breast Cancer and Immune Cell

LINE-associated cryptic splicing induces dsRNA-mediated interferon response and tumor immunity

Tumor-associated intronic editing of HNRPLL generates a novel splicing variant linked to cell proliferation

Hnrnp A1/A2 And Sf2/Asf Regulate Alternative Splicing Of Interferon Regulatory Factor-3 And Affect Immunomodulatory Functions In Human Non-Small Cell Lung Cancer Cells

Lncsnhg3 Drives Breast Cancer Progression by Epigenetically Increasing CSNK2A1 Expression Level.

SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine

Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway

SRSF2 plays an unexpected role as reader of m 5 C on mRNA, linking epitranscriptomics to cancer

The long noncoding RNA SNHG1 promotes tumor growth through regulating transcription of both local and distal genes

Dicer‐independent snRNA/snoRNA‐derived nuclear RNA 3 regulates tumor‐associated macrophage function by epigenetically repressing inducible nitric oxide synthase transcription

Pan-cancer pervasive upregulation of 3′ UTR splicing drives tumourigenesis